Summary of Ximai Foods Conference Call Company Overview - Ximai Foods has established itself as a leading player in the oatmeal industry, having listed on the A-share market in 2019 and achieving a market share of 31% in China [2][5][3] - The company has expanded its operations from Guangxi to the Southwest and established production bases in Hezhou and Hebei, creating a North-South market structure [3][4] Financial Performance - From 2014 to 2024, Ximai's revenue is projected to grow from 540 million RMB to 1.89 billion RMB, reflecting a compound annual growth rate (CAGR) of 13% [2][3] - Profit peaked at 160 million RMB in 2019 but has declined due to rising import prices of oats; however, profitability is expected to improve starting in 2025 as oat prices decrease [2][3][13] - Revenue targets for 2025, 2026, and 2027 are set at 2.2 billion, 2.5 billion, and 2.9 billion RMB respectively, indicating a strong growth trajectory [3][13] Market Dynamics - The Chinese breakfast oatmeal market is expected to reach 10.4 billion RMB by 2025, with a CAGR of 8% [2][5] - Oatmeal consumption in China is projected to grow, with a consumption volume of 234,000 tons by 2025, reflecting a CAGR of approximately 5% [5] - The retail market for oatmeal in China is highly concentrated, with the top three companies holding a market share of 56% [5] Product and Marketing Strategy - Ximai Foods offers a diverse product line, with compound oatmeal becoming the largest revenue contributor, accounting for 45% of total revenue by the end of 2024 [6][7] - The company has a clear marketing structure, with dedicated teams for brand management, online sales, offline channels, and new business development [7] - Online sales have seen significant growth, particularly on platforms like Douyin, where sales are expected to rise from 170 million RMB in 2022 to 620 million RMB by 2025 [7] Health and Wellness Initiatives - Ximai has actively entered the health and wellness sector, launching new products like "Shiyang Chongpao Powder," which are expected to create new growth avenues [2][8] - The establishment of Xiyi Company, a joint venture with Yiyangsheng Group, aims to develop food-medicine integrated products, leveraging both companies' strengths [11][12] Competitive Advantages - Ximai's market share increase in 2021 can be attributed to its localized strategies, product iterations, and rapid adaptation to emerging channels [9][10] - The company has effectively utilized a unique channel development model involving laid-off women to enhance distribution and brand loyalty [10] Future Outlook - The company anticipates double-digit revenue growth driven by demographic trends, the expansion of e-commerce, and breakthroughs in the health and wellness sector [13] - Key factors influencing profitability include declining oat prices, economies of scale, and an employee stock incentive plan [13][14] - The overall outlook is positive, with a buy rating recommended based on the company's robust growth potential and stable development trajectory [14]

开源证券研报指出，西麦食品增长根基稳步夯实，利润弹性释放可期，维持"增持"评级。1月公司进入 春节旺季备货阶段，市场需求相对较好，为收入增长提供支撑，同时成本红利继续释放，有望驱动公司 盈利弹性充分兑现。2025年纯燕麦推出有机燕麦等高附加值产品表现较好，增长有所提速；复合燕麦在 老品升级和新品放量下，增速较快并贡献主要增量，预计2026年燕麦主业将继续稳扎稳打，保障收入基 本盘。同时，2025年公司积极推进大健康第二增长曲线发展，Q4推出药食同源粉，在部分区域实现较 好动销和回转表现，预计2026年全国市场铺开后，有望贡献显著增量，成为重要增长极。2025年公司线 上渠道保持较强增长势能，其中抖音渠道增速较为亮眼，并且在控费提效策略推动下，渠道盈利能力在 逐季改善。 ...

原材料成本延续下降，叠加费用率优化，看好2026 年利润弹性 2025 年受益于澳麦原材料成本下行，公司前三季度毛利率同比提升1.03pct。2026年澳洲燕麦供需格局 继续改善，预计原料价格将延续下行趋势，驱动公司毛利率稳步上行，叠加公司费用管控能力持续优 化，盈利弹性有望加速兑现。 2025 年纯燕麦推出有机燕麦等高附加值产品表现较好，增长有所提速；复合燕麦在老品升级和新品放 量下，增速较快并贡献主要增量，预计2026 年燕麦主业将继续稳扎稳打，保障收入基本盘。同时， 2025 年公司积极推进大健康第二增长曲线发展，Q4 推出药食同源粉，在部分区域实现较好动销和回转 表现，预计2026 年全国市场铺开后，有望贡献显著增量，成为重要增长极。 线上渠道高增延续，线下新兴渠道拓展较好 2025 年公司线上渠道保持较强增长势能，其中抖音渠道增速较为亮眼，并且在控费提效策略推动下， 渠道盈利能力在逐季改善；天猫、京东等传统电商平台亦维持稳健增速，预计2026 年线上渠道仍将延 续高增长态势。线下渠道保持稳步增长，传统商超因调改增速放缓，新兴渠道成为线下主要增长引擎， 零食量贩持续扩充品类和门店覆盖数量，O2O 增加 ...

Summary of Ximai Foods Conference Call Company Overview - **Company**: Ximai Foods - **Industry**: Oat Products Key Points and Arguments Industry and Market Trends - Benefiting from a bumper harvest of oats in Australia, the average procurement price of oats is expected to decrease by at least 10% year-on-year in 2026, with a continued downward trend anticipated in 2027 [2][3] - The main raw material, imported oats from Australia, constitutes 35%-40% of production costs, which have been under pressure due to rising prices from 2018 to 2024 [3] Financial Performance and Projections - The company expects a stable revenue growth of approximately 20% over the next two to three years, driven by new product iterations and channel expansion [2][5] - A 10% decrease in Australian oat costs is projected to increase the company's gross margin by 2 percentage points [2][3] - The sales expense ratio has been around 30% in recent years but is expected to decline steadily due to scale effects and channel optimization [4] Product Development and Innovation - Continuous optimization of product structure with the introduction of high-end organic oats and composite oats, which have gross margins 8-10 percentage points higher than regular oats [2][3] - Development of high-value products such as gift boxes is contributing positively to gross margins [2] Channel Strategy - The company plans to enhance online and offline channel expense structures starting in 2027, focusing on precise online marketing and adjusting traditional supermarket costs [4][7] - Emphasis on new channels such as Douyin (TikTok), snack wholesale, and O2O (Online to Offline) models to capture market share [5][6] Health and Wellness Segment - The health and wellness segment is identified as a second growth curve, with new products like medicinal food powders and protein powders expected to contribute to mid-term revenue growth [2][10] - The revenue from the health segment is projected to exceed 2 billion yuan in 2026, aiming for 3 to 5 billion yuan in the following three years [10] Management and Strategic Changes - The new general manager has focused on product innovation, channel transformation, and health sector development since taking office in July 2025 [11] - A stock incentive plan was implemented in 2025, requiring a revenue growth of over 15% in the next two years to ensure stability [11] Valuation and Investment Potential - Current valuations do not reflect the potential benefits from cost reductions and growth in the health segment [12] - The company is recommended for investment focus due to expected dual improvements in performance and valuation driven by cost reductions and new channel breakthroughs [12] Additional Important Insights - The company is expected to increase its market share in the oat sector to 30% by 2027-2028, leveraging its leading position and consumer health trends [8][9] - The focus on young consumers and health-conscious demographics is driving product acceptance and market growth [8]

Core Insights - The company achieved a revenue of 1.696 billion yuan in the first three quarters, representing a year-on-year growth of 18.34%, with a net profit attributable to shareholders of 132 million yuan, up 21.90% [1] - In Q3 alone, the company reported a revenue of 547 million yuan, a year-on-year increase of 18.92%, and a net profit of 51 million yuan, growing by 21.00% [1] Group 1: Revenue Growth - Q3 revenue reached a new high, with a year-on-year growth of 18.92% to 547 million yuan, indicating strong competitive positioning in the industry [2] - All core product categories experienced double-digit growth in Q3, with compound oats benefiting from channel expansion and product innovation, outpacing overall company growth [2] - The offline channel network continues to expand, particularly in East China, maintaining the company's leading sales position in the industry [2] Group 2: Cost and Profitability - Q3 gross margin improved by 0.93 percentage points to 43.75%, primarily due to a decline in core raw material costs [3] - Q3 selling expense ratio decreased by 1.85 percentage points to 27.11%, attributed to effective cost control during the off-season [3] - Despite a reduction in government subsidies impacting profits, the company’s net profit margin increased by 0.14 percentage points to 9.31% in Q3, with a significant rise in operating-related net profit [3] Group 3: Future Outlook - The company is expected to maintain steady growth into Q4, driven by the upcoming Spring Festival season, increased volume of compound oats, and expansion in snack channels [3] - Long-term prospects are positive, with expectations for continued scale expansion benefiting from brand, channel, and supply chain advantages in the health food sector [3] Group 4: Investment Recommendations - The company has adjusted its revenue forecasts for 2025-2027 to 2.247 billion, 2.674 billion, and 3.102 billion yuan, respectively, and revised EPS estimates to 0.77, 0.98, and 1.17 yuan [4] - The price-to-earnings ratio for 2025 is projected at 28 times, maintaining a "buy" rating based on the latest performance report [4]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company demonstrated strong revenue resilience in Q3, with revenue growth of 18.9% year-on-year, reaching 5.5 billion yuan, and net profit growth of 21.0%, amounting to 0.5 billion yuan. The performance exceeded expectations, leading to a maintained profit forecast for 2025-2027 [3][4] - The company is focusing on product structure upgrades and multi-channel expansion, with significant growth in online sales, particularly on platforms like Douyin, which is expected to exceed 50% growth [4][5] - Cost reductions and effective expense management have contributed to an increase in net profit margin, which rose to 9.31% in Q3, up 0.14 percentage points year-on-year [6] Financial Performance Summary - For the first three quarters of 2025, the company reported revenue of 1.7 billion yuan, a year-on-year increase of 18.3%, and a net profit of 0.5 billion yuan, up 21.9% year-on-year. The forecast for net profit for 2025-2027 is 1.7 billion yuan, 2.3 billion yuan, and 2.8 billion yuan, representing year-on-year growth rates of 30.3%, 31.7%, and 23.6% respectively [3][7] - The gross margin for Q3 was 43.75%, an increase of 0.92 percentage points year-on-year, driven by cost reductions [6][11] - The company’s earnings per share (EPS) for 2025 is projected to be 0.78 yuan, with corresponding price-to-earnings (P/E) ratios of 26.9, 20.4, and 16.5 for 2025, 2026, and 2027 respectively [3][7] Business Development - The company is actively advancing its health product line, with new products expected to launch soon, which could provide a new growth curve [5] - The company has successfully launched a series of health food products, receiving positive sales feedback, indicating strong market acceptance [5]

Investment Rating - The report maintains a "Buy" investment rating for Ximai Food (002956.SZ) [8] Core Insights - The company's total operating revenue for Q1-Q3 2025 reached 1.696 billion yuan, representing an 18% year-on-year increase, while the net profit attributable to shareholders was 132 million yuan, up 22% year-on-year [1] - The gross profit margin for Q3 2025 increased by 1 percentage point to 43.75%, driven by product structure optimization and a decrease in raw material costs [2] - The launch of the medicinal food series in September received positive feedback, with a focus on market testing and consumer feedback collection in Q4 2025 [3] Financial Performance - For Q3 2025, total operating revenue was 547 million yuan, a 19% increase year-on-year, and the net profit attributable to shareholders was 51 million yuan, up 21% year-on-year [1] - The company has locked in raw material prices for the year, and costs are expected to continue declining, which will support sustained gross margin improvements [2] - The adjusted earnings per share (EPS) forecasts for 2025-2027 are 0.77, 1.02, and 1.27 yuan, respectively, with corresponding price-to-earnings (PE) ratios of 28, 21, and 17 times [8] Market Position and Strategy - Ximai Food is focusing on the oat category, with a strong emphasis on the health strategy, which is progressing smoothly [4] - The online sales channel continues to show rapid growth while maintaining cost control, and the company is expected to improve channel profitability further [3] - The company is adapting its product offerings in response to market conditions, including the introduction of new high-protein oat products in various retail channels [3]

Group 1: Market Overview - The domestic market indices showed positive performance with the Shanghai Composite Index closing at 3,828.58, up by 0.22% [4] - The Shenzhen Component Index and the ChiNext Index also experienced gains, indicating a general upward trend in the market [4] Group 2: Company Insights - Zhongheng Electric (002364.SZ) is establishing a joint venture to expand its overseas HVDC product market, with a total investment of 200 million Singapore dollars [6] - Sanwang Communication (688618.SH) reported a stable overall operating situation, with a focus on new fields for growth [7] - Baili Tianheng (688506.SH) is developing an EGFR×HER3 ADC that is expected to become a cornerstone drug for tumors, with HER2 ADC showing potential [11] - Ximai Food (002956.SZ) reported significant growth in its oat product segment, benefiting from cost reductions and increased sales [15] Group 3: Financial Performance - Zhongheng Electric achieved a revenue of 889 million yuan in H1 2025, a year-on-year increase of 14.3%, driven primarily by its data center power business [7] - Sanwang Communication's H1 revenue reached 172 million yuan, up 10.05% year-on-year, although net profit decreased by 36.72% [8] - Baili Tianheng forecasts revenues of 2.251 billion yuan for 2025, with a projected net profit of -527 million yuan [13] - Ximai Food's H1 revenue was 1.149 billion yuan, reflecting an 18.1% increase, with compound oats being a key growth driver [15] Group 4: Investment Recommendations - Zhongheng Electric is rated "Buy-B" with projected EPS of 0.37, 0.56, and 0.78 for 2025-2027 [6] - Sanwang Communication is expected to stabilize and grow in new fields, maintaining a focus on innovation [7] - Baili Tianheng is rated "Buy-B" with a focus on its ADC pipeline and potential market impact [13] - Ximai Food is rated "Add-A" with expected EPS of 0.78, 1.00, and 1.25 for 2025-2027, driven by strong sales growth in oat products [15]

Investment Rating - The report assigns an "Accumulate-A" rating to the company for the first time [1][4]. Core Views - The company has shown significant growth in its core product, composite oats, which accounted for 48.4% of total revenue in the first half of the year, generating 556 million yuan, a year-on-year increase of 27.6% [3]. - The overall revenue for the first half of 2025 reached 1.149 billion yuan, reflecting an 18.1% year-on-year growth, with a net profit of 81 million yuan, up 22.5% [2][3]. - The company is expanding its offline channel partnerships and benefiting from new retail contributions, with southern region revenue growing by 20.1% and northern region by 13.3% [3]. Summary by Sections Financial Performance - In H1 2025, the company's gross margin improved to 43.6%, an increase of 1.1 percentage points year-on-year, driven by lower procurement costs for Australian oats and a higher proportion of high-margin composite oats [3]. - The net profit margin for H1 was 7.1%, up 0.3 percentage points year-on-year [3]. Revenue and Profit Forecast - The company is projected to achieve revenues of 2.29 billion yuan, 2.74 billion yuan, and 3.31 billion yuan for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 20.8%, 19.7%, and 20.7% [4][7]. - Expected EPS for 2025, 2026, and 2027 are 0.78 yuan, 1.00 yuan, and 1.25 yuan, respectively, with corresponding P/E ratios of 27.3, 21.4, and 17.2 [4][7]. Market Position and Strategy - The company is focusing on the health sector and expanding its product offerings through various channel partnerships, which is expected to drive future growth [4].

Group 1 - The core growth driver for the company in recent years has been the compound oatmeal, with new product launches such as the medicinal food series powder and the Seven Whites and Eight Treasures oatmeal, catering to consumer demand for traditional Chinese health products [1] - The company has plans to continue launching new products in the same series to meet consumer needs [1] Group 2 - Last year, the company acquired 60% of Desai Kanggu through a strategic merger, involving a payment of 15 million for partial equity transfer and an additional 21 million for capital increase [2] - Desai Kanggu is projected to achieve over 30 million in revenue in the first half of 2025, with a year-on-year growth of approximately 10%, and has started to turn a profit since the second quarter [3] Group 3 - The primary consumption scenario for the oatmeal category is breakfast, accounting for nearly 60% of total consumption, although this proportion has decreased compared to previous years [3] - The industry is actively working on expanding consumption scenarios, which has shown significant results, and it is anticipated that the proportion of breakfast consumption may further decline as more scenarios are developed to meet hidden consumer demands [3]